Hans Thorleif Moller
Oprichter bij Ranger Biotechnologies A/S
Profiel
Hans Thorleif Moller is the founder.
He founded Profylakse ApS in 1999.
He also founded Ranger Biotechnologies A in 2009, where he currently holds the title of Chief Executive Officer & Director.
In addition to his founding positions, Dr. Moller has worked as a Principal at CEM Innovation A.
Actieve functies van Hans Thorleif Moller
| Bedrijven | Functie | Begin |
|---|---|---|
Ranger Biotechnologies A/S
 Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Oprichter | 01-07-2009 |
Eerdere bekende functies van Hans Thorleif Moller
| Bedrijven | Functie | Einde |
|---|---|---|
CEM Innovation A/S
 CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark. | Corporate Officer/Principal | 18-03-2011 |
Profylakse ApS
 Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
CEM Innovation A/S
CEM Innovation A/S Construction MaterialsNon-Energy Minerals CEM Innovation A/S develops and supplies cement products. The firm's products are used in the engineering, construction, and other industries. The company is headquartered in Sonderso, Denmark. | Non-Energy Minerals |
Profylakse ApS
Profylakse ApS Pharmaceuticals: MajorHealth Technology Profylakse is a Danish biotech company, founded in 1999 by scientists from University of Southern Denmark. Profylakse has an experienced development team, working within microbiology, immunology and protein chemistry for 3 decades. Its focus is on the development of antiviral, not vaccines, especially against influenza and parainfluenza viruses. This has resulted in its antiviral recombinant SAP. Profylakse´s investor base is the Danish Technological Institute and the South Danish Innovations. | Health Technology |
Ranger Biotechnologies A/S
Ranger Biotechnologies A/S Miscellaneous Commercial ServicesCommercial Services Mirrx Therapeutics A/S provides protein production technology. Its technology Blockmirs, is steric antisense blockers that bind to specific microRNA binding sites in target RNAs to thereby prevent microRNA binding to the same site. The company was founded by Hans Thorleif Møller on July 1, 2009 and is headquartered in Vejle, Denmark. | Commercial Services |
